- Home
- ULCC vs ELVN Comparison
ULCC vs ELVN Comparison
Compare ULCC & ELVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ULCC
- ELVN
- Stock Information
- Founded
- ULCC 1994
- ELVN 2016
- Country
- ULCC United States
- ELVN United States
- Employees
- ULCC N/A
- ELVN N/A
- Industry
- ULCC Air Freight/Delivery Services
- ELVN Biotechnology: Pharmaceutical Preparations
- Sector
- ULCC Consumer Discretionary
- ELVN Health Care
- Exchange
- ULCC Nasdaq
- ELVN Nasdaq
- Market Cap
- ULCC 1.1B
- ELVN 1.2B
- IPO Year
- ULCC 2021
- ELVN 2020
- Fundamental
- Price
- ULCC $3.68
- ELVN $23.97
- Analyst Decision
- ULCC Hold
- ELVN Strong Buy
- Analyst Count
- ULCC 9
- ELVN 5
- Target Price
- ULCC $5.63
- ELVN $41.20
- AVG Volume (30 Days)
- ULCC 3.9M
- ELVN 433.1K
- Earning Date
- ULCC 11-05-2025
- ELVN 11-07-2025
- Dividend Yield
- ULCC N/A
- ELVN N/A
- EPS Growth
- ULCC N/A
- ELVN N/A
- EPS
- ULCC N/A
- ELVN N/A
- Revenue
- ULCC $3,778,000,000.00
- ELVN N/A
- Revenue This Year
- ULCC $1.14
- ELVN N/A
- Revenue Next Year
- ULCC $13.33
- ELVN $20.05
- P/E Ratio
- ULCC N/A
- ELVN N/A
- Revenue Growth
- ULCC 4.60
- ELVN N/A
- 52 Week Low
- ULCC $2.89
- ELVN $13.30
- 52 Week High
- ULCC $10.26
- ELVN $29.79
- Technical
- Relative Strength Index (RSI)
- ULCC 36.60
- ELVN 62.60
- Support Level
- ULCC $4.11
- ELVN $20.10
- Resistance Level
- ULCC $4.36
- ELVN $22.88
- Average True Range (ATR)
- ULCC 0.24
- ELVN 0.96
- MACD
- ULCC -0.04
- ELVN 0.13
- Stochastic Oscillator
- ULCC 1.35
- ELVN 92.43
About ULCC Frontier Group Holdings Inc.
Frontier Group Holdings Inc is an ultra-low-cost carrier whose business is focused on Low Fares Done Right. The company owns a fleet of 120 Airbus single-aisle aircraft, consisting of 13 A320ceos, 82 A320neos, 21 A321ceos and 4 A321neos. The use of these aircraft, their seating configuration, weight-saving tactics, and baggage process have all contributed to the ability to continue to be the fuel-efficient of all the U.S. The Company is managed as a single business unit that provides air transportation for passengers. Majority of revenue is from Domestic flight follow by International.
About ELVN Enliven Therapeutics Inc.
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.